Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer

Authors: Professor Rob Anderson , Hoyle M, Moxham T, Napier M
Published: 1st September 2009
Theme: Complex Care
Type: Paper
DOI: 10.3310/hta13suppl2/10

Reference:

Bond M, Hoyle M, Moxham T, Napier M, Anderson R. Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer. Health Technology Assessment 2009;13(2): 69-74.